名稱 | BCR-ABL1 T315I/BaF3 |
型號(hào) | CBP73190 |
報(bào)價(jià) | ![]() |
特點(diǎn) | BCR-ABL1 [T315I]/BaF3,母細(xì)胞:BaF3,凍存條件:90% FBS+10% DMSO; |
產(chǎn)品搜索
相關(guān)文章
- 聚焦靶點(diǎn)BRAF——BRAF相關(guān)突變細(xì)胞強(qiáng)勢(shì)登場(chǎng)
- LTβR信號(hào)通路誘導(dǎo)三級(jí)淋巴結(jié)構(gòu)的形成,促進(jìn)趨化因子的表達(dá)
- 中國(guó)細(xì)胞資源庫(kù),南京科佰生物
- 【產(chǎn)品推介】MSI標(biāo)準(zhǔn)品
- 甲基丙二酸血癥(MMA)標(biāo)準(zhǔn)品上新
- 喝熱茶或使食管癌風(fēng)險(xiǎn)增加5倍
- BCR-ABL激酶抑制劑細(xì)胞篩選模型
- 自身免疫疾病潛力靶點(diǎn)——IL-5藥篩細(xì)胞模型
- ATCC細(xì)胞株開(kāi)發(fā)的四階段簡(jiǎn)介
- 特定細(xì)胞株的培養(yǎng)條件怎么獲取到呢?
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73190BCR-ABL1 T315I/BaF3

- 詳細(xì)內(nèi)容
CBP73190 | |
I. Introduction | |
Cell Line Name: | BCR-ABL1 [T315I]/BaF3 |
Host Cell: | Ba/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
II.Background | |
Presence of a BCR-ABL1 fusion gene is necessary for the pathogenesis of CML. In up to 95% of cases, a t(9;22) (q34;q11) translocation results in the BCR-ABL1 fusion gene (Faderl et al. 1999). This translocation results in the Philadephia chromosome. In rare CML cases lacking the traditional t(9;22) translocation, other translocations result in the creation of the BCR-ABL1 fusion gene, which sometimes involve multiple chromosomes. | |
III. Representative Data | |
1. WB of BCR-ABL1 [T315I]/BaF3 | |
2. Sanger of BCR-ABL1 [T315I]/BaF3 Figure 2. BCR-ABL1 T315I/BaF3 T315I Figure 3. BCR-ABL1 T315I/BaF3 Fusion | |
3. Anti-proliferation assay | |
![]() | |
Figure 4. CTG Proliferation Assay of BaF3 BCR-ABL1 T315I Cells. |